The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...

A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug ...

A study done by the University of Minnesota (U of M) found that early adult deaths are on the rise in the U.S., with COVID-19 ...

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...

Cal Yee Farm LLC is recalling chocolate and other products. Some have been given a Class I classification by the FDA which is their highest risk level.

The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

Robert F. Kennedy Jr. also disclosed that he had reached at least one settlement agreement with a company or individual that ...

AbbVie's acquisition of Allergan significantly increased the firm's debt level. We expect the firm's net debt position to peak at close to $70 billion in 2020 but given the strong cash flows of AbbVie ...

The FDA’s framework for AI regulation, while robust for premarket evaluation, would benefit from more specific mechanisms for continuous monitoring of AI performance in diverse real-world settings.

When a drug smuggler busted in Butte, Montana, wouldn’t flip and become an informant, he went on the run. Then a domestic ...

The fentanyl crisis represents a clear and present danger to US national security, requiring a coordinated, sustained, and ...

Early adult death in the US has significantly increased since 2010, with mortality rates exceeding prepandemic levels, even ...